KRN-7000(S34)
DC67239
View product →
GSK2245035 is a highly potent and selective intranasal Toll-Like receptor 7 (TLR7) agonist with preferential Type-1 interferon (IFN)-stimulating properties. GSK2245035 has pEC50s of 9.3 and 6.5 for IFNα and TFNα. GSK2245035 effectively suppresses allergen-induced Th2 cytokine production in human peripheral blood cell cultures. GSK2245035 is used for asthma.
| CAS No. | 1207629-49-9 |
| Chemical Name | GSK2245035 |
| Synonyms | GSK2245035;5L3SX16QBQ;GTPL9254;LFMPVTVPXHNXOT-HNNXBMFYSA-N;SB19815;compound 32 [PMID: 26861551];J3.609.218A;(S)-6-amino-2-(pentan-2-yloxy)-9-(5-(piperidin-1-yl)pentyl)-7,9-dihydro-8H-purin-8-one;6-amino-2-[(2S)-pentan-2-yloxy]-9-[5-(piperidin-1-yl)pentyl]-8,9-dihydro-7H-purin-8-one;6-amino-2-{[(1S)-1-methylbutyl]oxy}-9[5-(1-piperidinyl) pentyl]-7,9-dihydro-8H-purin-8-one;8H-Purin-8-one, 6-amino-7;8H-Purin-8-one, 6-amino-7,9-dihydro-2-((1S)-1-methylbutoxy)-9-(5-(1-piperidinyl)pentyl)-;6-amino-2-[(2S)-pentan-2-yl]oxy-9-(5-piperidin-1-ylpentyl)-7H-purin-8-one;GSK-2245035;HY-118250;F3409-0744;AKOS032954203;DA-63925;compound 32 (PMID: 26861551);6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one;6-amino-7,9-dihydro-2-[(1S)-1-methylbutoxy]-9-[5-(1-piperidinyl)pentyl]-8H-purin-8-one;6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl) pentyl]-7,9-dihydro-8H-purin-8-one;G16656;CHEMBL4297492;SCHEMBL565847;NSC-853260;GLXC-15811;UNII-5L3SX16QBQ;CS-0065520;6-amino-2-((1-methylbutyl)oxy)-9-(5-(1-piperidinyl)pentyl)-7,9-dihydro-8H-purin-8-one;MS-26512;1207629-49-9;NSC853260 |
| SMILES | O(C1N=C(C2=C(N=1)N(C(N2)=O)CCCCCN1CCCCC1)N)[C@@H](C)CCC |
| Formula | C20H34N6O2 |
| M.Wt | 390.522964000702 |
| Purity | >98% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | Not available |
| Product classification | Adjuvant Molecules |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 25.6067 mL | 5.1213 mL | 2.5607 mL |
| 25 mg | 64.0167 mL | 12.8033 mL | 6.4017 mL |
| 50 mg | 128.0334 mL | 25.6067 mL | 12.8033 mL |
| 100 mg | 256.0669 mL | 51.2134 mL | 25.6067 mL |
| 250 mg | 640.1672 mL | 128.0334 mL | 64.0167 mL |
Contact our team with the catalog number and requested quantity.